Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for melanoma, cutaneous malignant, susceptibility to, 7 has been reported in the published literature.
No clinical trials have been registered for melanoma, cutaneous malignant, susceptibility to, 7.
102 publications have been identified in PubMed for melanoma, cutaneous malignant, susceptibility to, 7. Research spans Epidemiology / Natural History (29%), Basic Science / Preclinical (20%), and Diagnostic / Biomarker (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 30 | 29% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:51 AM UTC
Online Mendelian Inheritance in Man
Laboratory research |
20 |
20% |
Testing and diagnosis research | 19 | 19% |
Research summaries | 13 | 13% |
Clinical study results | 9 | 9% |
Patient case studies | 7 | 7% |
New treatment approaches | 3 | 3% |
Other research | 1 | 1% |
Lee HM (2026). [PMID: 42099186](https://pubmed.ncbi.nlm.nih.gov/42099186/). *Arch Craniofac Surg*. [Epidemiology / Natural History]
Kondo H (2026). [PMID: 41574632](https://pubmed.ncbi.nlm.nih.gov/41574632/). *Vet Pathol*. [Diagnostic / Biomarker]
Bristow IR (2026). [PMID: 42165691](https://pubmed.ncbi.nlm.nih.gov/42165691/). *J Foot Ankle Res*. [Review / Meta-Analysis]
Kelbert J (2026). [PMID: 41352132](https://pubmed.ncbi.nlm.nih.gov/41352132/). *J Clin Neurosci*. [Epidemiology / Natural History]
Dummer R (2026). [PMID: 41698381](https://pubmed.ncbi.nlm.nih.gov/41698381/). *Lancet Oncol*. [Clinical Trial Publication]
Tang N (2026). [PMID: 41697477](https://pubmed.ncbi.nlm.nih.gov/41697477/). *Clin Exp Med*. [Diagnostic / Biomarker]
Yi Z (2026). [PMID: 41500176](https://pubmed.ncbi.nlm.nih.gov/41500176/). *Int Immunopharmacol*. [Basic Science / Preclinical]
Wang Y (2026). [PMID: 41804614](https://pubmed.ncbi.nlm.nih.gov/41804614/). *Expert Rev Anticancer Ther*. [Diagnostic / Biomarker]
Babic Z (2026). [PMID: 42075613](https://pubmed.ncbi.nlm.nih.gov/42075613/). *Medicina (Kaunas)*. [Epidemiology / Natural History]
Oksuz S (2026). [PMID: 41504775](https://pubmed.ncbi.nlm.nih.gov/41504775/). *J Cancer Res Clin Oncol*. [Clinical Trial Publication]